alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                           EXHIBIT 11
                 STANLEY FURNITURE COMPANY, INC.
   SCHEDULE OF COMPUTATION OF EARNINGS (LOSS) PER COMMON SHARE
              (In thousands, except per share data)
<TABLE>
                                             1994       1993
<S>                                         <C>        <C>
Net income (loss) used in calculating
  primary and fully diluted earnings
  (loss) per common share:
Continuing operations.................      $5,116     $5,280
Discontinued operations...............      (2,758)           
  Net income..........................      $2,358     $5,280

Primary earnings (loss) per common
  share:
Weighted average shares outstanding....      4,725      3,792
Add shares issuable assuming excercise
  of stock options.....................         19         10

    Weighted average number of shares
      used in calculating primary 
      earnings (loss) per common share.      4,744      3,802

Primary earnings (loss) per common
  share:
Continuing operations..................     $ 1.08     $ 1.39
Discontinued operations................       (.58)           
  Primary earnings per common share....     $  .50     $ 1.39

Fully diluted earnings (loss) per
  common share:
Weighted average shares outstanding....      4,725      3,792
Add shares issuable assuming excer-
  cise of stock options................         19         51
    Weighted average number of shares
      used in calculating fully diluted
      earnings (loss) per common share.      4,744      3,843
 
Fully diluted earnings (loss) per
  common share:
Continuing operations.................      $ 1.08     $ 1.37
Discontinued operations...............        (.58)            
  Fully diluted earnings per common
    share.............................      $  .50     $ 1.37

</TABLE>
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Spear & Jackson, Inc. (the "Company")
on Form 10-QSB for the period ended June 30, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Dennis Crowley,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934;
and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


/s/Dennis Crowley
   -----------------------
   Dennis Crowley
   Chief Executive Officer

August 5, 2003
Exhibit 23.1





                            Consent of Independent Auditors




               The Board of Directors
               National Bankshares, Inc.

               We consent to incorporation by reference in Registration
               Statement No. 333-79979 on Form S-8 of National Bankshares, Inc.
               of our report dated January 23, 2002, relating to the
               consolidated balance sheets of National Bankshares, Inc. and
               subsidiaries as of December 31, 2001 and 2000, and the related
               consolidated statements of income, changes in stockholders'
               equity, and cash flows for the years then ended, which report is
               included in the December 31, 2001 Annual Report on Form 10-K of
               National Bankshares, Inc.


               /s/Yount, Hyde & Barbour, P.C.


               Winchester, Virginia
               March 29, 2002
Case 1:00-cr-00093-SAS Document 46 Filed 11/02/2005 Page 1 of 3
Case 1:00-cr-00093-SAS Document 46 Filed 11/02/2005 Page 2 of 3
Case 1:00-cr-00093-SAS Document 46 Filed 11/02/2005 Page 3 of 3
Exhibit 32.1





CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


(18 U.S.C. SECTION 1350)







In connection with the accompanying Quarterly Report of Genta Incorporated (the “Company”) on Form 10-Q for the quarter ended September 30, 2010 (the “Report”), I, Raymond P. Warrell, Jr., M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:           November 11, 2010




/s/ RAYMOND P. WARRELL, JR., M.D.*


Name:         Raymond P. Warrell, Jr., M.D.


Title:           Chairman and Chief Executive Officer














* A signed original of this written statement required by Section 906 has been provided to Genta Incorporated and will be retained by Genta Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF OHIO
WESTERN DIVISION
David Jones,
Petitioner(s),

Case Number: 1:17¢v741
vs.

Judge Susan J. Dlott
Warden, Marion Correctional Institution,
Respondent(s).
ORDER

This matter is before the Court pursuant to the Order of General Reference in the United
States District Court for the Southern District of Ohio Western Division to United States
Magistrate Judge Karen L. Litkovitz. Pursuant to such reference, the Magistrate Judge reviewed
the pleadings and filed with this Court on February 11, 2019 a Report and Recommendation
(Doc. 29). Subsequently, the petitioner filed objections to such Report and Recommendation
(Doc. 32).

The Court has reviewed the comprehensive findings of the Magistrate Judge and
considered de novo all of the filings in this matter. Upon consideration of the foregoing, the
Court does determine that such Recommendation should be adopted.

Accordingly, respondent’s motion to dismiss (Doc. 13) is GRANTED, the petition for a
writ of habeas corpus pursuant to 28 U.S.C. §2254 (Doe. 1) is DISMISSED with prejudice on the
ground that the petition is time-barred under 28 U.S.C. §2244(d).

A certificate of appealability will not issue with respect to any of the claims for relief

alleged in the petition, which the court has concluded are barred from review on a procedural


ground, because under the first prong of the applicable two-part standard enunciated in Slack v
McDaniel, 529 U.S. 473, 484-85 (2000), “jurists of reason” will not find it debatable whether the
Court is correct in its procedural ruling.

With respect to any application by petitioner to proceed on appeal in forma pauperis, the
Court will certify pursuant to 28 U.S.C. §1915(a)(3) that an appeal of an Order adopting the
Report and Recommendation will not be taken in “good faith.” Therefore, petitioner is DENIED
leave to appeal in forma pauperis upon a showing of financial necessity. See Fed. R. App.P.
24(a); Kincade v. Sparkman, 117 F.3d 949, 952 (6" Cir. 1997).

IT IS SO ORDERED.

titan. 4 Shit

Judge Susan J. Gfott
United States District Court
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 503 Agreed to Senate (ATS)]

<DOC>

116th CONGRESS
  2d Session
S. RES. 503

 Commending the University of West Florida Argonauts football team for 
   its National Collegiate Athletic Association Division II national 
                         championship victory.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 13, 2020

    Mr. Scott of Florida (for himself and Mr. Rubio) submitted the 
        following resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION

 
 Commending the University of West Florida Argonauts football team for 
   its National Collegiate Athletic Association Division II national 
                         championship victory.

Whereas, on December 21, 2019, the University of West Florida Argonauts football 
        team (referred to in this preamble as the ``Argonauts'') defeated the 
        Minnesota State University Mavericks by a score of 48 to 40 in the 
        National Collegiate Athletic Association Division II national 
        championship game in McKinney, Texas;
Whereas the Argonauts returned to the national championship game in 2019 for the 
        second time in the last 3 years;
Whereas the Argonauts won the first national football championship for the 
        University of West Florida a mere 4 years after the football program was 
        established at the university in 2015;
Whereas the Argonauts finished the 2019 football season with a 13-2 record; and
Whereas head coach Pete Shinnick and each player on the Argonauts' team roster 
        should be congratulated for a successful football season: Now, 
        therefore, be it
    Resolved, That the Senate--
            (1) commends the University of West Florida Argonauts 
        football team for its National Collegiate Athletic Association 
        Division II national championship victory in football;
            (2) recognizes the hard work, determination, and excellence 
        exhibited by the players, coaches, support staff, and student 
        body of the University of West Florida; and
            (3) congratulates--
                    (A) the University of West Florida and the city of 
                Pensacola, Florida;
                    (B) the fans of the University of West Florida 
                Argonauts football team; and
                    (C) the alumni of the University of West Florida 
                throughout the world.
                                 <all>
```
**EXHIBIT 32.1**

STATEMENT OF CHIEF EXECUTIVE OFFICEROF PREMIERE GLOBAL SERVICES, INC.PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO  § 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Premiere Global Services, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2008 as filed with the Securities and Exchange Commission on the datehereof (the “Report”), the undersigned, Boland T. Jones, Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

|       | (1)      | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                |
|--------------------------------|-------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|                           |
|                           | (2)      | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|                           |

|               | /s/ Boland T. Jones            |
|--------------------|--------------------------------|
|     | Boland T. Jones                |
|               | Chief Executive Officer        |
|               | Premiere Global Services, Inc. |
|               | November 7, 2008               |

----
EXHIBIT 32.1

SECTION 1350 CHIEF EXECUTIVE OFFICER

I, Ira D. Lawrence, Chief Executive Officer of SciClone Pharmaceuticals, Inc. (the
"Registrant"), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

(1) the Quarterly Report on Form 10-Q of the Registrant, to which this certification is attached as
an exhibit (the "Report"), fully complies with the requirements of section 13(a) of the Securities Exchange Act
of 1934 (15 U.S.C. 78m); and

(2) the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Registrant.

|Date:  August 9, 2005 | /s/  Ira D. Lawrence, M.D.
                               Ira D. Lawrence, M.D.
                               Chief Executive Officer
|--------------------- | --------------------------------------------------------------------------------------------------------------------------------------

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to SciClone Pharmaceuticals,
Inc. and will be retained by SciClone Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.

---
Ray Arp, 

In the United States District Court 

for the Southern District of Ohio 

Western Division at Dayton 

On behalf of himself and those 

similarly situated, 

Case No. 3:18-cv-119 

Plaintiff, Judge Walter H. Rice 

V. 

Hohla & Wyss Enterprises, LLC, 

Defendants. 

Order and Decision Granting 

Plaintiffs Motion for Final Settlement Approval 

Before the Court is Plaintiffs Motion for Final Approval (Doc. 55) of a settlement on 

behalf of members of an FLSA collective action and Rule 23 class action. On October 26, 2020, 

the Court held a Final Fairness Hearing on this matter. Plaintiffs Motion is now ripe for 

adjudication. 

I. Background

This is a wage and hour lawsuit brought on behalf of a class of delivery drivers at 

approximately seven Jimmy John's franchise locations in the Dayton area. Plaintiff is one of 

those drivers. Plaintiff raises a number of claims under the Fair Labor Standards Act and Ohio's 

wage and hour laws. Those claims are discussed below. 

A. Under-reimbursement of Vehicle Expenses

1 

Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 1 of 18 PAGEID #: 533
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 2 of 18 PAGEID #: 534
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 3 of 18 PAGEID #: 535
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 4 of 18 PAGEID #: 536
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 5 of 18 PAGEID #: 537
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 6 of 18 PAGEID #: 538
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 7 of 18 PAGEID #: 539
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 8 of 18 PAGEID #: 540
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 9 of 18 PAGEID #: 541
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 10 of 18 PAGEID #: 542
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 11 of 18 PAGEID #: 543
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 12 of 18 PAGEID #: 544
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 13 of 18 PAGEID #: 545
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 14 of 18 PAGEID #: 546
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 15 of 18 PAGEID #: 547
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 16 of 18 PAGEID #: 548
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 17 of 18 PAGEID #: 549
Case: 3:18-cv-00119-WHR Doc #: 57 Filed: 11/05/20 Page: 18 of 18 PAGEID #: 550
Exhibit 32.1


Certification of the Chief Executive Officer
 Pursuant to 18 U.S.C. 1350
 (Section 906 of the Sarbanes-Oxley Act of 2002)
   I, H. Lynn Harton, Chief Executive Officer of The South Financial Group, Inc. (“TSFG”) certify that to the best of my knowledge, based upon a review of the annual report on Form 10-K for the period ended December 31, 2009 of TSFG (the “Report”):
   (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
 (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of TSFG.
 
  /s/ H. Lynn Harton
 H. Lynn Harton
 Chief Executive Officer
 The South Financial Group, Inc.
 March 16, 2010
 
 A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to The South Financial Group, Inc. and will be retained by The South Financial Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2

                  Certification by the Chief Financial Officer
           Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

      I, William P. Keane, the Chief Financial Officer of Genta Incorporated, a
Delaware corporation (the "Company"), hereby certify that:

1.    The Company's quarterly report on Form 10-Q for the period ended September
      30, 2003 (the "Form 10-Q") fully complies with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.    The information contained in the Form 10-Q fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.


      /s/ WILLIAM P. KEANE
      ------------------------------
      Name:  William P. Keane
      Title: Chief Financial Officer
In the Senate of the United States, 

March 26 (legislative day, March 25), 2010. 

Resolved, That the bill from the House of Representatives (H.R. 4573) entitled ‘‘An Act to urge the Secretary of 

the Treasury to instruct the United States Executive Directors at the International Monetary Fund, the World Bank, 

the Inter-American Development Bank, and other multilateral development institutions to use the voice, vote, and influence of the United States to cancel immediately and completely Haiti’s debts to such institutions, and for other purposes.’’, do pass with the following 

AMENDMENTS: 

1 Ω1æOn page 3, line 4, after øprovision¿ insert: , before 

2 February 1, 2015, 

3 Ω2æOn page 3, lines 18 and 19, strike ‘‘relief’’ and all 

4 that follows through ‘‘Haiti.’’ and insert: relief and debt 

5 service relief for Haiti and, before February 1, 2015, to pro6 vide grants for Haiti. 
2 

† HR 4573 EAS 

1 Ω3æOn page 4, line 7, after øHaiti’s future¿ insert: and 

2 future generations 

Attest: 

Secretary. 

111TH CONGRESS 

2D SESSION H.R. 4573 

AMENDMENTS
Exhibit M-2

Case: 2:18-cv-00272-MHW-CMV Doc #: 87-37 Filed: 02/01/21 Page: 1 of 2 PAGEID #: 3275
Date Description of Services Time

4/2/2018 Corresp w/ plffs Ray and Argento re legal team 0.5

4/5/2018 Conference call with co-counsel 0.9

4/6/2018 Review correspondence from cocounsel 0.1

4/21/2018 Corresp w/ Argento 0.3

5/4/2018 Corresp w/ Argento 0.4

5/25/2018 Corresp to plffs Argento and Ray 0.3

6/14/2018 Review correspondence from cocounsel 0.1

6/18/2018 Corresp to plffs Argento and Ray 0.3

6/21/2018 conference call with co-counsel 1.2

6/22/2018 Send materials to E. Jeffers 0.2

6/28/2018 conference call with co-counsel 0.9

7/17/2018 Arrange tech logistics for pretrial conference 1.0

7/17/2018 Corresp w/ plff Ray and ACLU OH attys 0.2

7/19/2018 Review corresp from plff Ray 0.1

8/2/2018 Corresp w/ E. Bonham re litigation deadlines 0.2

8/13/2018 Corresp to plffs Argento and Ray 0.2

8/15/2018 Corresp to plffs Argento and Ray 0.7

8/16/2018 Corresp w/ J. Roach re substitution of counsel 0.1

10/10/2018 Corresp w/ plff Ray and ACLU OH attys 0.5

10/26/2018 Corresp to plffs Argento and Ray 0.5

Total Time 8.7

Hourly Rate x $ 150.00 

Lodestar Fees $ 1,305.00

Emma Keeshin

Case: 2:18-cv-00272-MHW-CMV Doc #: 87-37 Filed: 02/01/21 Page: 2 of 2 PAGEID #: 3276
EXHIBIT 32.2

SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER AND

MEMBER OF THE OFFICE OF THE PRESIDENT

I, Richard A. Waldron, Chief Financial Officer and Member of
the Office of the President of SciClone Pharmaceuticals, Inc. (the
"Registrant"), do hereby certify in accordance with 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based
on my knowledge:

(1) the Quarterly Report on Form 10-Q of the Registrant, to
which this certification is attached as an exhibit (the "Report"),
fully complies with the requirements of Section 13(a) of the Securities Exchange
Act of 1934 (15 U.S.C. 78m); and

(2) the information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of
the Registrant.

|Date:  May 9, 2005 | /s/  Richard A. Waldron                                          
|------------------ | -----------------------------------------------------------------
|                   | Richard A. Waldron                                               
|                   | Chief Financial Officer and
Member of the Office of the President

A signed original of this written statement
required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been
provided to SciClone Pharmaceuticals, Inc. and will be retained by SciClone
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.

---
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                      25,890,000
<SECURITIES>                                   638,000
<RECEIVABLES>                                3,777,000
<ALLOWANCES>                                         0
<INVENTORY>                                 98,717,000
<CURRENT-ASSETS>                           129,022,000
<PP&E>                                       2,346,000
<DEPRECIATION>                                 813,000
<TOTAL-ASSETS>                             130,555,000
<CURRENT-LIABILITIES>                       99,704,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,000
<OTHER-SE>                                  30,845,000
<TOTAL-LIABILITY-AND-EQUITY>               130,555,000
<SALES>                                     44,393,000
<TOTAL-REVENUES>                            44,393,000
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            26,856,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           5,486,000
<INCOME-PRETAX>                             12,051,000
<INCOME-TAX>                                 4,815,000
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 7,236,000
<EPS-PRIMARY>                                     1.55
<EPS-DILUTED>                                     1.51
        

</TABLE>